Edwards Lifesciences Corp
XETRA:EWL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edwards Lifesciences Corp
XETRA:EWL
|
US |
|
Abl Group ASA
F:26Q
|
NO |
|
K
|
Kabel Deutschland Holding AG
XHAM:KD8
|
DE |
|
M
|
Mckesson Corp
XMUN:MCK
|
US |
|
FormPipe Software AB
F:F3J
|
SE |
Wall St Price Targets
EWL Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for EWL is 85.55 EUR with a low forecast of 74.98 EUR and a high forecast of 100.88 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EWL's stock price target?
Price Target
85.55
EUR
According to Wall Street analysts, the average 1-year price target for EWL is 85.55 EUR with a low forecast of 74.98 EUR and a high forecast of 100.88 EUR.
What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 15%.
What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 27%.
